RTW Biotech Opportunities (LON:RTW – Get Free Report)’s stock price dropped 0.4% during trading on Wednesday . The stock traded as low as GBX 2.39 and last traded at GBX 2.40. 382,650 shares were traded during trading, a decline of 53% from the average daily volume of 806,257 shares. The stock had previously closed at GBX 2.41.
RTW Biotech Opportunities Price Performance
The company has a debt-to-equity ratio of 20.05, a quick ratio of 0.81 and a current ratio of 0.15. The stock has a market capitalization of £7.84 million, a P/E ratio of 0.04 and a beta of 0.78. The stock’s fifty day simple moving average is GBX 2.26 and its two-hundred day simple moving average is GBX 2.16.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Recommended Stories
- Five stocks we like better than RTW Biotech Opportunities
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
